Yahoo
NasdaqCM - Nasdaq Real Time Price USD

DarioHealth Corp. (DRIO)

2.3750 -0.3500 (-12.84%)
At close: November 6 at 4:00:00 PM EST
2.5500 +0.1750 (+7.37%)
After hours: November 6 at 7:48:14 PM EST

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Erez Raphael
CEO & Director 924.74k -- 1973
Ms. Chen Franco-Yehuda
CFO, Treasurer & Secretary 374.23k -- 1984
Mr. Steven C. Nelson
Consultant 478.21k -- 1973
Dov Oppenheim
Co-Founder & Production Chief -- -- --
Lara Dodo
Chief Operations Officer -- -- --
Zoe Harrison
VP of Accounting & Corporate Development -- -- --
Kat Parrella
Investor Relations Manager -- -- --
Ms. Mona Dean
Chief Compliance Officer -- -- --
Claudia Levi
Content & Communications Manager -- -- --
Mr. Rob Halpern
SVP of Marketing -- -- --

DarioHealth Corp.

322 W. 57th Street
New York, NY 10019
United States
https://www.dariohealth.com
Sector: 
Healthcare
Full Time Employees: 
160

Description

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Corporate Governance

DarioHealth Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 12, 2026 at 1:30 PM UTC

DarioHealth Corp. Earnings Date

Recent Events

November 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 4, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 21, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 11, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 22, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 10, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 13, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 7, 2026 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

April 13, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 25, 2026 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: